ABSTRACT

Examines Critical Decisions for Transitioning Lab Science to a Clinical SettingThe development of therapeutic pharmaceutical compounds is becoming more expensive, and the success rates for getting such treatments approved for marketing and to the patients is decreasing. As a result, translational medicine (TM) is becoming increasingly important in

chapter 4|18 pages

Biomarker Development

chapter 5|26 pages

Targeted Clinical Trials

chapter 8|22 pages

Model Selection/Validation*